Pharmacologic Management of Spasticity Following Stroke

Joann Gallichio

doi:10.1093/ptj/84.10.973

Pharmacologic Management of Spasticity Following Stroke

Joann Gallichio

Research output: Contribution to journal › Review article › peer-review

Abstract

Spasticity is a pervasive and debilitating condition that frequently occurs following upper motor neuron (UMN) lesions. Although the exact incidence of spasticity is unknown, it is likely that it affects more than half a million people in the United States alone, and more than 12 million people worldwide. Following stroke, approximately 65% of individuals develop spasticity.

Original language	American English
Pages (from-to)	973-981
Number of pages	9
Journal	Physical Therapy
Volume	84
Issue number	10
DOIs	https://doi.org/10.1093/ptj/84.10.973
State	Published - Oct 1 2004

ASJC Scopus Subject Areas

General Medicine

Keywords

Muscle Relaxants
Muscle Spasticity
Muscle Tonus
Neuromuscular Blocking Agents
Stroke Rehabilitation
Drugs
Stroke
Spasticity

Disciplines

Medicine and Health Sciences

Access to Document

10.1093/ptj/84.10.973

Cite this

@article{2db68006739b49bebf771f3af0afe316,

title = "Pharmacologic Management of Spasticity Following Stroke",

abstract = "Spasticity is a pervasive and debilitating condition that frequently occurs following upper motor neuron (UMN) lesions. Although the exact incidence of spasticity is unknown, it is likely that it affects more than half a million people in the United States alone, and more than 12 million people worldwide. Following stroke, approximately 65\% of individuals develop spasticity.",

keywords = "Muscle Relaxants, Muscle Spasticity, Muscle Tonus, Neuromuscular Blocking Agents, Stroke Rehabilitation, Drugs, Stroke, Spasticity",

author = "Joann Gallichio",

year = "2004",

month = oct,

day = "1",

doi = "10.1093/ptj/84.10.973",

language = "American English",

volume = "84",

pages = "973--981",

journal = "Physical Therapy",

issn = "0031-9023",

number = "10",

}

TY - JOUR

T1 - Pharmacologic Management of Spasticity Following Stroke

AU - Gallichio, Joann

PY - 2004/10/1

Y1 - 2004/10/1

N2 - Spasticity is a pervasive and debilitating condition that frequently occurs following upper motor neuron (UMN) lesions. Although the exact incidence of spasticity is unknown, it is likely that it affects more than half a million people in the United States alone, and more than 12 million people worldwide. Following stroke, approximately 65% of individuals develop spasticity.

AB - Spasticity is a pervasive and debilitating condition that frequently occurs following upper motor neuron (UMN) lesions. Although the exact incidence of spasticity is unknown, it is likely that it affects more than half a million people in the United States alone, and more than 12 million people worldwide. Following stroke, approximately 65% of individuals develop spasticity.

KW - Muscle Relaxants

KW - Muscle Spasticity

KW - Muscle Tonus

KW - Neuromuscular Blocking Agents

KW - Stroke Rehabilitation

KW - Drugs

KW - Stroke

KW - Spasticity

UR - https://nsuworks.nova.edu/hpd_pt_facarticles/9

UR - https://www.scopus.com/pages/publications/4644332691

UR - https://www.scopus.com/pages/publications/4644332691#tab=citedBy

U2 - 10.1093/ptj/84.10.973

DO - 10.1093/ptj/84.10.973

M3 - Review article

SN - 0031-9023

VL - 84

SP - 973

EP - 981

JO - Physical Therapy

JF - Physical Therapy

IS - 10

ER -

Pharmacologic Management of Spasticity Following Stroke

Abstract

ASJC Scopus Subject Areas

Keywords

Disciplines

Access to Document

Other files and links

Fingerprint

Cite this